Association of Thyroid Hormone and Insulin‐Like Growth Factor‐1 Levels With Autism Spectrum Disorders: A Systematic Review and Meta‐Analysis
- 12 May 2025
- journal article
- review article
- Published by Wiley in Autism Research
- Vol. 18 (7) , 1497-1512
Abstract
The action of the thyroid hormones and insulin‐like growth factor 1 (IGF‐1) is interdependent. The levels of thyroid hormone and IGF‐1 were reported to be altered in individuals with autism spectrum disorder (ASD), but the results were controversial. This study aims to compare levels of thyroxine, triiodothyronine, thyroid stimulating hormone, and IGF‐1 between the ASD group and neurotypical controls. PubMed, Web of Science, Cochrane, and Embase databases were searched for eligible observational studies. We calculated pooled standardized mean difference (SMD) with 95% confidence intervals (CIs) of our data using a random or fixed effect model. The search strategy provided a total of 1710 articles, of which 16 articles were quantitatively analyzed. The total number of included participants was 2399 (1285 cases and 1114 controls). The meta‐analysis revealed no significantly changed blood levels of thyroxine, free triiodothyronine, free thyroxine, and IGF‐1 of subjects with ASD compared to non‐autistic controls. The blood TSH levels were significantly lower in ASD subjects than in controls ( n = 859, Hedges' g = −1.18, 95% CI: −2.17 to −0.20, p = 0.02). Subgroup‐analysis results showed that blood free triiodothyronine ( n = 153, Hedges' g = −0.74, 95% CI: −1.08 to −0.40, p < 0.0001, I 2 = 2%), free thyroxine ( n = 153, Hedges' g = −0.72, 95% CI: −1.31 to −0.14, p = 0.02, I 2 = 66%), and IGF‐1 ( n = 397; Hedges' g = −0.92; 95% CI: −1.30 to −0.55, p < 0.00001, I 2 = 63%) levels were significantly reduced in subjects with severe ASD symptoms. Individuals with severe ASD may experience a dysfunction of the hypothalamic–pituitary–thyroid axis, and further studies are warranted to determine the correlation between thyroid hormone and IGF‐1 levels and disease severity. Trial Registration: ClinicalTrials.gov identifiers: NCT01970345Keywords
This publication has 66 references indexed in Scilit:
- Global prevalence of autism: A systematic review updateAutism Research, 2022
- Insulin‐Like Growth Factor and Insulin‐Like Growth Factor Receptor Expression in Human Idiopathic Autism Fusiform Gyrus TissueAutism Research, 2020
- Neonatal Thyroid Stimulating Hormone and Subsequent Diagnosis of Autism Spectrum Disorders and Intellectual DisabilityAutism Research, 2019
- Analysis and functional characterization of sequence variations in ligand binding domain of thyroid hormone receptors in autism spectrum disorder (ASD) patientsAutism Research, 2017
- Neonatal thyroid hormone levels in association with autism spectrum disorderAutism Research, 2016
- Persistence of megalencephaly in a subgroup of young boys with autism spectrum disorderAutism Research, 2016
- Increased Surface Area, but not Cortical Thickness, in a Subset of Young Boys With Autism Spectrum DisorderAutism Research, 2015
- Association of gestational maternal hypothyroxinemia and increased autism riskAnnals of Neurology, 2013
- Early Generalized Overgrowth in Boys With AutismArchives of General Psychiatry, 2011
- Are thyroid hormone concentrations at birth associated with subsequent autism diagnosis?Autism Research, 2011